Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
3 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Cash flows used in operating activities    
Net loss for the period $ (701,391) $ (578,713)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 64,044  
Depreciation and amortization 1,603 375
Inventory write-off (Note 7) 3,546
Unrealized loss on marketable securities 9,630  
Change in working capital:    
Accounts and other receivables (5,365) (26,630)
Inventory (29,435) (13,808)
Prepaid expenses 10,302 91,551
Accounts payable and accrued liabilities 72,499 27,280
Due to related parties 13,799 (17,672)
Unearned revenue   (6,250)
Net cash used in operating activities (564,314) (520,321)
Cash flows used in investing activities    
Investment in Poviva   (70,000)
Patent (44,368) (15,715)
Equipment (122,832)  
Net cash used in investing activities (167,200) (85,715)
Cash flows from financing activities    
Proceeds from issuance of equity 1,649,190 282,402
Net cash from financing activities 1,649,190 282,402
Increase (decrease) in cash 917,676 (323,634)
Cash, beginning of period 1,727,184 2,533,337
Cash, end of period 2,644,860 2,209,703
Supplemental information of cash flows:    
Interest paid in cash 0 0
Income tax paid in cash $ 0 0
Reclassification of NCI to additional paid in capital on acquisition   $ 238,476